{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T15:35:14Z","timestamp":1771256114916,"version":"3.50.1"},"update-to":[{"DOI":"10.1371\/journal.pntd.0005951","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T00:00:00Z","timestamp":1512604800000}}],"reference-count":53,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T00:00:00Z","timestamp":1511740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"European Community\u2019s Seventh Framework Programme","award":["No.603181"],"award-info":[{"award-number":["No.603181"]}]},{"name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases (US)"},{"name":"Fondo de Investigaciones Sanitarias","award":["ISCIII-RETICRD16\/0027\/0008-FEDER"],"award-info":[{"award-number":["ISCIII-RETICRD16\/0027\/0008-FEDER"]}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"DOI":"10.1371\/journal.pntd.0005951","type":"journal-article","created":{"date-parts":[[2017,11,27]],"date-time":"2017-11-27T13:53:35Z","timestamp":1511790815000},"page":"e0005951","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":43,"title":["Pre-clinical antigenicity studies of an innovative multivalent vaccine for human visceral leishmaniasis"],"prefix":"10.1371","volume":"11","author":[{"given":"Pedro","family":"Cec\u00edlio","sequence":"first","affiliation":[]},{"given":"Bego\u00f1a","family":"P\u00e9rez-Cabezas","sequence":"additional","affiliation":[]},{"given":"Laura","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[]},{"given":"Javier","family":"Moreno","sequence":"additional","affiliation":[]},{"given":"Eugenia","family":"Carrillo","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9 M.","family":"Requena","sequence":"additional","affiliation":[]},{"given":"Epifanio","family":"Fichera","sequence":"additional","affiliation":[]},{"given":"Steven G.","family":"Reed","sequence":"additional","affiliation":[]},{"given":"Rhea N.","family":"Coler","sequence":"additional","affiliation":[]},{"given":"Shaden","family":"Kamhawi","sequence":"additional","affiliation":[]},{"given":"Fabiano","family":"Oliveira","sequence":"additional","affiliation":[]},{"given":"Jesus G.","family":"Valenzuela","sequence":"additional","affiliation":[]},{"given":"Luigi","family":"Gradoni","sequence":"additional","affiliation":[]},{"given":"Reinhard","family":"Glueck","sequence":"additional","affiliation":[]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2392-6087","authenticated-orcid":true,"given":"Anabela","family":"Cordeiro-da-Silva","sequence":"additional","affiliation":[]}],"member":"340","published-online":{"date-parts":[[2017,11,27]]},"reference":[{"issue":"3","key":"ref1","doi-asserted-by":"crossref","first-page":"e0004349","DOI":"10.1371\/journal.pntd.0004349","article-title":"A Historical Overview of the Classification, Evolution, and Dispersion of Leishmania Parasites and Sandflies","volume":"10","author":"M Akhoundi","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"ref2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s10096-011-1276-0","article-title":"Leishmaniasis: new insights from an old and neglected disease","volume":"31","author":"S Antinori","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrmicro2608","article-title":"Leishmaniasis: complexity at the host-pathogen interface","volume":"9","author":"P Kaye","year":"2011","journal-title":"Nat Rev Microbiol"},{"issue":"9496","key":"ref4","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(05)67629-5","article-title":"Advances in leishmaniasis","volume":"366","author":"HW Murray","year":"2005","journal-title":"Lancet"},{"key":"ref5","unstructured":"WHO. Status of endemicity of visceral leishmaniasis: Global Health Observatory; 2013 [09\/28\/2016]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/gho\/neglected_diseases\/leishmaniasis\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/gho\/neglected_diseases\/leishmaniasis\/en\/<\/ext-link>."},{"key":"ref6","unstructured":"WHO. Control of Leishmaniasis: Report of a meeting of the WHO Expert Committee on the Control of Leishmaniasis. WHO technical report series n\u00ba 949 2010."},{"issue":"7385","key":"ref7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/bmj.326.7385.377","article-title":"Leishmaniasis: new approaches to disease control","volume":"326","author":"CR Davies","year":"2003","journal-title":"BMJ"},{"issue":"3","key":"ref8","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.1038\/cti.2014.4","article-title":"Vaccines to prevent leishmaniasis","volume":"3","author":"R Kumar","year":"2014","journal-title":"Clin Transl Immunology"},{"issue":"45","key":"ref9","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1016\/j.vaccine.2005.07.001","article-title":"Failure of a multi-subunit recombinant leishmanial vaccine (MML) to protect dogs from Leishmania infantum infection and to prevent disease progression in infected animals","volume":"23","author":"L Gradoni","year":"2005","journal-title":"Vaccine"},{"issue":"6","key":"ref10","doi-asserted-by":"crossref","first-page":"e1000484","DOI":"10.1371\/journal.ppat.1000484","article-title":"Vector transmission of leishmania abrogates vaccine-induced protective immunity","volume":"5","author":"NC Peters","year":"2009","journal-title":"PLoS Pathog"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.meegid.2014.07.028","article-title":"What&apos;s behind a sand fly bite? The profound effect of sand fly saliva on host hemostasis, inflammation and immunity","volume":"28","author":"M Abdeladhim","year":"2014","journal-title":"Infect Genet Evol"},{"issue":"5","key":"ref12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.celrep.2015.09.058","article-title":"Exosome Secretion by the Parasitic Protozoan Leishmania within the Sand Fly Midgut","volume":"13","author":"VD Atayde","year":"2015","journal-title":"Cell Rep"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"223","DOI":"10.3389\/fmicb.2012.00223","article-title":"The role of leishmania proteophosphoglycans in sand fly transmission and infection of the Mammalian host","volume":"3","author":"ME Rogers","year":"2012","journal-title":"Front Microbiol"},{"issue":"10","key":"ref14","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1084\/jem.188.10.1941","article-title":"Development of a natural model of cutaneous leishmaniasis: powerful effects of vector saliva and saliva preexposure on the long-term outcome of Leishmania major infection in the mouse ear dermis","volume":"188","author":"Y Belkaid","year":"1998","journal-title":"J Exp Med"},{"issue":"5495","key":"ref15","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1126\/science.290.5495.1351","article-title":"Protection against cutaneous leishmaniasis resulting from bites of uninfected sand flies","volume":"290","author":"S Kamhawi","year":"2000","journal-title":"Science"},{"issue":"22","key":"ref16","doi-asserted-by":"crossref","first-page":"7845","DOI":"10.1073\/pnas.0712153105","article-title":"Immunity to a salivary protein of a sand fly vector protects against the fatal outcome of visceral leishmaniasis in a hamster model","volume":"105","author":"R Gomes","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref17","doi-asserted-by":"crossref","first-page":"e1169","DOI":"10.1371\/journal.pntd.0001169","article-title":"Lutzomyia longipalpis saliva or salivary protein LJM19 protects against Leishmania braziliensis and the saliva of its vector, Lutzomyia intermedia","volume":"5","author":"NM Tavares","year":"2011","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"ref18","doi-asserted-by":"crossref","first-page":"e0004322","DOI":"10.1371\/journal.pntd.0004322","article-title":"Intradermal Immunization of Leishmania donovani Centrin Knock-Out Parasites in Combination with Salivary Protein LJM19 from Sand Fly Vector Induces a Durable Protective Immune Response in Hamsters","volume":"10","author":"JA Fiuza","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"ref19","doi-asserted-by":"crossref","first-page":"e2751","DOI":"10.1371\/journal.pntd.0002751","article-title":"Enhanced protective efficacy of nonpathogenic recombinant leishmania tarentolae expressing cysteine proteinases combined with a sand fly salivary antigen","volume":"8","author":"F Zahedifard","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"ref20","doi-asserted-by":"crossref","first-page":"e1000441","DOI":"10.1371\/journal.ppat.1000441","article-title":"Sand fly salivary proteins induce strong cellular immunity in a natural reservoir of visceral leishmaniasis with adverse consequences for Leishmania","volume":"5","author":"N Collin","year":"2009","journal-title":"PLoS Pathog"},{"issue":"11","key":"ref21","doi-asserted-by":"crossref","first-page":"7160","DOI":"10.4049\/jimmunol.174.11.7160","article-title":"Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation: evidence for mixed Th1- and Th2-like responses in visceral leishmaniasis","volume":"174","author":"R Basu","year":"2005","journal-title":"J Immunol"},{"issue":"42","key":"ref22","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1016\/j.vaccine.2007.08.001","article-title":"Protective immunization against visceral leishmaniasis using Leishmania sterol 24-c-methyltransferase formulated in adjuvant","volume":"25","author":"Y Goto","year":"2007","journal-title":"Vaccine"},{"issue":"2","key":"ref23","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1128\/IAI.73.2.812-819.2005","article-title":"Cross-protective efficacy of a prophylactic Leishmania donovani DNA vaccine against visceral and cutaneous murine leishmaniasis","volume":"73","author":"I Aguilar-Be","year":"2005","journal-title":"Infect Immun"},{"issue":"46","key":"ref24","doi-asserted-by":"crossref","first-page":"5822","DOI":"10.1016\/j.vaccine.2008.08.065","article-title":"Cysteine proteinase type III is protective against Leishmania infantum infection in BALB\/c mice and highly antigenic in visceral leishmaniasis individuals","volume":"26","author":"N Khoshgoo","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"ref25","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1038\/cti.2015.6","article-title":"From mouse to man: safety, immunogenicity and efficacy of a candidate leishmaniasis vaccine LEISH-F3+GLA-SE","volume":"4","author":"RN Coler","year":"2015","journal-title":"Clin Transl Immunology"},{"issue":"3","key":"ref26","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/infdis\/jir769","article-title":"GLA-SE, a synthetic toll-like receptor 4 agonist, enhances T-cell responses to influenza vaccine in older adults","volume":"205","author":"H Behzad","year":"2012","journal-title":"J Infect Dis"},{"issue":"48","key":"ref27","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.1016\/j.vaccine.2013.08.064","article-title":"Evaluation of safety and immunogenicity of recombinant influenza hemagglutinin (H5\/Indonesia\/05\/2005) formulated with and without a stable oil-in-water emulsion containing glucopyranosyl-lipid A (SE+GLA) adjuvant","volume":"31","author":"JJ Treanor","year":"2013","journal-title":"Vaccine"},{"issue":"Suppl 5","key":"ref28","doi-asserted-by":"crossref","first-page":"B10","DOI":"10.1016\/S0264-410X(02)00513-3","article-title":"New technology platforms in the development of vaccines for the future","volume":"20","author":"R Gluck","year":"2002","journal-title":"Vaccine"},{"issue":"17\u201318","key":"ref29","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0264-410X(02)00103-2","article-title":"Virosome-mediated delivery of protein antigens to dendritic cells","volume":"20","author":"L Bungener","year":"2002","journal-title":"Vaccine"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1038\/cti.2014.13","article-title":"Increase in DNA vaccine efficacy by virosome delivery and co-expression of a cytolytic protein","volume":"3","author":"T Gargett","year":"2014","journal-title":"Clin Transl Immunology"},{"issue":"1","key":"ref31","doi-asserted-by":"crossref","first-page":"e16333","DOI":"10.1371\/journal.pone.0016333","article-title":"Development and characterization of synthetic glucopyranosyl lipid adjuvant system as a vaccine adjuvant","volume":"6","author":"RN Coler","year":"2011","journal-title":"PLoS One"},{"issue":"7","key":"ref32","doi-asserted-by":"crossref","first-page":"e41144","DOI":"10.1371\/journal.pone.0041144","article-title":"Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140","volume":"7","author":"MA Arias","year":"2012","journal-title":"PLoS One"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"478","DOI":"10.3389\/fimmu.2016.00478","article-title":"Interleukin-27 Early Impacts Leishmania infantum Infection in Mice and Correlates with Active Visceral Disease in Humans","volume":"7","author":"B Perez-Cabezas","year":"2016","journal-title":"Front Immunol"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1084\/jem.20051639","article-title":"Antigen targeting to dendritic cells elicits long-lived T cell help for antibody responses","volume":"203","author":"SB Boscardin","year":"2006","journal-title":"J Exp Med"},{"issue":"290","key":"ref35","doi-asserted-by":"crossref","first-page":"290ra90","DOI":"10.1126\/scitranslmed.aaa3043","article-title":"A sand fly salivary protein vaccine shows efficacy against vector-transmitted cutaneous leishmaniasis in nonhuman primates","volume":"7","author":"F Oliveira","year":"2015","journal-title":"Sci Transl Med"},{"issue":"4","key":"ref36","doi-asserted-by":"crossref","first-page":"e226","DOI":"10.1371\/journal.pntd.0000226","article-title":"Immunity to distinct sand fly salivary proteins primes the anti-Leishmania immune response towards protection or exacerbation of disease","volume":"2","author":"F Oliveira","year":"2008","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"ref37","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1586\/erv.11.15","article-title":"Influenza virosomes as a vaccine adjuvant and carrier system","volume":"10","author":"C Moser","year":"2011","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1365-2567.1998.00423.x","article-title":"Low antigen dose favours selection of somatic mutants with hallmarks of antibody affinity maturation","volume":"93","author":"A Gonzalez-Fernandez","year":"1998","journal-title":"Immunology"},{"issue":"41","key":"ref39","doi-asserted-by":"crossref","first-page":"14852","DOI":"10.1073\/pnas.1403271111","article-title":"Antigen affinity and antigen dose exert distinct influences on CD4 T-cell differentiation","volume":"111","author":"S Keck","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"947606","DOI":"10.1155\/2014\/947606","article-title":"Immunomodulation in human dendritic cells leads to induction of interferon-gamma production by Leishmania donovani derived KMP-11 antigen via activation of NF-kappaB in Indian kala-azar patients","volume":"2014","author":"R Chaudhary","year":"2014","journal-title":"Biomed Res Int"},{"issue":"2","key":"ref41","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1473-3099(05)70085-2","article-title":"Recombinant DNA-derived leishmania proteins: from the laboratory to the field","volume":"5","author":"J Kubar","year":"2005","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.1365-3083.2005.01581.x","article-title":"Effect of LACK and KMP11 on IFN-gamma production by peripheral blood mononuclear cells from cutaneous and mucosal leishmaniasis patients","volume":"61","author":"LP Carvalho","year":"2005","journal-title":"Scand J Immunol"},{"issue":"15","key":"ref43","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/j.vaccine.2013.02.025","article-title":"Heterologous priming-boosting with DNA and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of Leishmania (Leishmania) donovani","volume":"31","author":"R Guha","year":"2013","journal-title":"Vaccine"},{"issue":"9","key":"ref44","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.vaccine.2008.12.053","article-title":"KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major","volume":"27","author":"S Bhaumik","year":"2009","journal-title":"Vaccine"},{"issue":"3\u20134","key":"ref45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S0264-410X(01)00341-3","article-title":"Attenuated Toxoplasma gondii ts-4 mutants engineered to express the Leishmania antigen KMP-11 elicit a specific immune response in BALB\/c mice","volume":"20","author":"JR Ramirez","year":"2001","journal-title":"Vaccine"},{"issue":"7","key":"ref46","doi-asserted-by":"crossref","first-page":"e0004771","DOI":"10.1371\/journal.pntd.0004771","article-title":"Molecular Diversity between Salivary Proteins from New World and Old World Sand Flies with Emphasis on Bichromomyia olmeca, the Sand Fly Vector of Leishmania mexicana in Mesoamerica","volume":"10","author":"M Abdeladhim","year":"2016","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"ref47","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.jaci.2015.08.001","article-title":"Highly increased levels of IgE antibodies to vaccine components in children with influenza vaccine-associated anaphylaxis","volume":"137","author":"M Nagao","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"ref48","unstructured":"WHO. WHO Expert Committee on Biological Standardization: guidelines of nonclinical evaluation of vaccines WHO Technical Report Series 927: 2005."},{"issue":"1","key":"ref49","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1186\/s13071-016-1669-0","article-title":"Comment on &quot;Regulation of immunity during visceral Leishmania infection&quot; and further discussions about the role of antibodies in infections with Leishmania","volume":"9","author":"LG Gardinassi","year":"2016","journal-title":"Parasit Vectors"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3389\/fimmu.2014.00241","article-title":"Biomarkers of safety and immune protection for genetically modified live attenuated leishmania vaccines against visceral leishmaniasis\u2014discovery and implications","volume":"5","author":"S Gannavaram","year":"2014","journal-title":"Front Immunol"},{"key":"ref51","first-page":"480","article-title":"Deception and manipulation: the arms of leishmania, a successful parasite","volume":"5","author":"P Cecilio","year":"2014","journal-title":"Front Immunol"},{"issue":"8","key":"ref52","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1002\/eji.201242428","article-title":"TLR-mediated distinct IFN-gamma\/IL-10 pattern induces protective immunity against murine visceral leishmaniasis","volume":"42","author":"J Paul","year":"2012","journal-title":"Eur J Immunol"},{"issue":"2","key":"ref53","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.immuni.2009.05.012","article-title":"Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose","volume":"31","author":"M Saraiva","year":"2009","journal-title":"Immunity"}],"updated-by":[{"DOI":"10.1371\/journal.pntd.0005951","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,12,7]],"date-time":"2017-12-07T00:00:00Z","timestamp":1512604800000}}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pntd.0005951","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,22]],"date-time":"2018-10-22T22:51:02Z","timestamp":1540248662000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0005951"}},"subtitle":[],"editor":[{"given":"Hechmi","family":"Louzir","sequence":"first","affiliation":[]}],"short-title":[],"issued":{"date-parts":[[2017,11,27]]},"references-count":53,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2017,11,27]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0005951","relation":{"new_version":[{"id-type":"doi","id":"10.1371\/journal.pntd.0005951","asserted-by":"object"}]},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,27]]}}}